HOME >> BIOLOGY >> NEWS
A novel molecular dictator 'with a conscience' discovered

University of New South Wales (UNSW) researchers have uncovered an important naturally occurring mechanism in the body where "bad" cells that cause blockages in our blood vessels are kept under strict growth control, while "good" cells that keep our blood vessels free of clots and growths are left unaffected.

The discovery is expected to benefit those who will need heart coronary bypass surgery, an angioplasty - the mechanical widening of a narrowed or totally blocked blood vessel - or will undergo haemodialysis.

Professor Levon Khachigian, from UNSWs Centre for Vascular Research, who previously pioneered "molecular assassin" drug technology, describes this novel mechanism he discovered as a molecular dictatorship with a conscience.

"The dictator is a specific gene suppressor called YY1, which has the therapeutically appealing capacity to differentiate between certain cell types when it goes about its activity," says Professor Khachigian.

This key finding has just been published in the world's premier cardiovascular research journal, Circulation Research.

Professor Khachigian's research provides new hope in tackling the global problems of coronary bypass graft failure, and restenosis - the closing or narrowing of an artery that was previously opened by a procedure such as angioplasty.

"While the most effective way to head off restenosis is a drug-coated stent, the drugs that sit on these stents inhibit the growth of good cells as well as the bad.

If you had to have catheter intervention to re-open an occluded artery, for sustained symptom-free benefit you would be hoping for suppressed smooth muscle cell growth, without affecting endothelial cell growth, says Professor Khachigian.

And thats exactly what happens when we simply top up blood vessels with the bodys natural reserves of YY1."


'"/>

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-422-934-024
University of New South Wales
22-Jul-2007


Page: 1

Related biology news :

1. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
2. UB scientist discovers novel iron-copper alliance
3. Researchers pit novel version of common virus against cancer
4. UCLA researchers discover novel pathway that may promote immune system balance
5. pHLIP, a novel technology to locate and treat tumors
6. Bioluminescence at the service of a novel cerebral imaging technique
7. Application of Genomatix in silico methods reveals novel cancer associated genes
8. Two studies: Speeding development of novel tracer for prostate cancer
9. Erythrocyte G protein as a novel target for malarial chemotherapy
10. U of MN researchers find novel genes critical in organ development
11. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... 2019 , ... R3 Stem Cell is now offering its comprehensive Online ... code to use during checkout is FIFTYOFF and applies to both the one month ... regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. A couple years ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... for drugs, biologics, gene therapies, and consumer health products, today announced it will ... Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , On Wednesday, Nov. ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine ... ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, ... UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... , ... November 06, 2019 , ... ... through off-the-record collaboration and dialogue, today announces its East/West CEO conference ... in San Francisco. , Kicking off the week of the J.P. ...
(Date:11/5/2019)... , ... November 05, 2019 , ... ... announced it has received CE Mark for its Fusion Bx 2.0 prostate fusion ... and user-friendly interface, the Fusion Bx 2.0 will give urologists across Europe the ...
(Date:11/2/2019)... TORONTO (PRWEB) , ... October 31, 2019 , ... ... are not always used to communicating with each other: study managers, principal investigators, ... cause misunderstandings if a party is not informed of the latest data, potentially ...
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, ... pioneer tellic. drug360 brings tellic’s expertise in biomedical language processing and machine ... quickly uncover relationships between genes, diseases, variants, phenotypes, and other biomedical entities. ...
Breaking Biology Technology:
Cached News: